Xponance Inc. raised its holdings in Enovix Co. (NASDAQ:ENVX – Free Report) by 17.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,810 shares of the company’s stock after acquiring an additional 1,738 shares during the period. Xponance Inc.’s holdings in Enovix were worth $128,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Fifth Third Bancorp boosted its position in Enovix by 66.7% in the fourth quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock valued at $27,000 after buying an additional 1,000 shares in the last quarter. Hollencrest Capital Management lifted its holdings in Enovix by 61.4% in the fourth quarter. Hollencrest Capital Management now owns 5,256 shares of the company’s stock valued at $57,000 after buying an additional 2,000 shares during the period. R Squared Ltd acquired a new position in shares of Enovix in the 4th quarter valued at about $64,000. SRS Capital Advisors Inc. bought a new position in shares of Enovix during the 4th quarter worth approximately $87,000. Finally, Quest Partners LLC grew its holdings in Enovix by 318.5% in the third quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock worth $77,000 after purchasing an additional 6,294 shares during the period. Institutional investors own 50.92% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have commented on ENVX shares. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a report on Thursday, February 20th. Craig Hallum dropped their target price on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Enovix has an average rating of “Moderate Buy” and a consensus target price of $20.30.
Insider Activity
In other news, CEO Rajendra K. Talluri sold 300,000 shares of the company’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $9.35, for a total value of $2,805,000.00. Following the completion of the transaction, the chief executive officer now directly owns 2,045,301 shares in the company, valued at approximately $19,123,564.35. This represents a 12.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 15.70% of the stock is owned by company insiders.
Enovix Stock Down 6.6 %
Enovix stock opened at $7.48 on Friday. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of -5.16 and a beta of 1.93. The firm has a 50 day simple moving average of $9.92 and a 200 day simple moving average of $10.04. Enovix Co. has a 1-year low of $5.70 and a 1-year high of $18.68. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99.
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01. The company had revenue of $9.72 million for the quarter, compared to analyst estimates of $8.77 million. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. On average, analysts predict that Enovix Co. will post -1.01 earnings per share for the current year.
Enovix Profile
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Read More
- Five stocks we like better than Enovix
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- MarketBeat Week in Review – 03/24 – 03/28
- How to find penny stocks to invest and trade
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- High Flyers: 3 Natural Gas Stocks for March 2022
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.